Gilead Sciences to close Seattle office; shutdown impacts 72 …
22 hours ago · by Taylor Soper on November 13, 2024 at 9:52 pm. Biopharma giant Gilead Sciences will shut down its office in Seattle’s Eastlake neighborhood, the company confirmed to GeekWire on Wednesday. A ...
Gilead to lay off 72 staffers, shutter Seattle R&D office
10 hours ago · Gilead lays off 72 workers in Seattle, plans to shutter R&D support site. Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to ...
Gilead Sciences to close its Seattle office, lay off employees
22 hours ago · Gilead arrived in Seattle in 2006 with its acquisition of Corus Pharma for $365 million. In 2008, it signed a 106,000-square-foot long-term lease in an Alexandria Real Estate Equities-owned ...
COVID drugmaker to close Seattle office, laying off 72 workers
5 hours ago · Nov. 14, 2024 at 2:23 pm. Gilead Sciences, a biopharma giant known for developing COVID-19 and HIV/AIDS treatments, is closing its Seattle office, according to a state filing on Wednesday. The ...
Gilead to close Philadelphia and Seattle offices, make job cuts
7 hours ago · Gilead to close Philadelphia and Seattle offices, make job cuts. November 14, 2024 03:30 PM EST. People.
Gilead Sciences Latest News - Puget Sound Business Journal
Jan 16, 2018 · Biotech giant Gilead Sciences to close its Seattle office, lay off employees. October 17, 2019, 6:07 PM EST Career & Workplace.
HIV Drugmaker Gilead Reports Strongest Quarterly Performance …
Nov 7, 2024 · Also Read: Gilead Sciences/Merck’s Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks HIV product sales increased 9% to $5.1 billion, with Biktarvy sales ...
Newsroom | Gilead - Gilead Sciences
Gilead Sciences Announces Third Quarter 2024 Financial Results. November 05, 2024. Kite to Highlight Industry-Leading CAR T-Cell Therapy Portfolio at ASH 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World. October 22, 2024.
Gilead 3rd-quarter results beat Wall Street estimates, raises outlook
Nov 6, 2024 · In This Article: GILD. By Deena Beasley. (Reuters) -Gilead Sciences reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%, leading ...
Gilead Sciences Announces Third Quarter 2024 Financial Results
Nov 6, 2024 · During the third quarter 2024 Gilead generated $4.3 billion in operating cash flow. During the third quarter 2024 Gilead paid dividends of $983 million and repurchased $300 million of common stock ...
- Some results have been removed